½ÃÀ庸°í¼­
»óǰÄÚµå
1468362

Ä¡·á¿ë ħ´ë ½ÃÀå º¸°í¼­ : Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Therapeutic Beds Market Report by Product (Clinical Beds, Household Beds, Accessories), Application (Acute Care Beds, Critical Care Beds, Long-term Beds), End User (Hospital and Clinics, Reproductive Care Centers, and Others), and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 137 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Ä¡·á¿ë ħ´ë ½ÃÀå ±Ô¸ð´Â 2023³â 45¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 66¾ï ´Þ·¯¿¡ ´ÞÇϰí 2024-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 4.23%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

ÀÓ»ó Ä¡·á¿ë ħ´ë´Â ȯÀÚÀÇ Æí¾ÈÇÔÀ» ±Ø´ëÈ­Çϰí ÀÇ·áÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇØ Æ¯º°È÷ °í¾ÈµÈ ħ´ëÀÔ´Ï´Ù. ÀÌ Ä§´ë´Â ³ëÀÎ ¿ä¾ç¿ø, Áø´Ü ½ÇÇè½Ç, ¿Ü·¡ Áø·á¼Ò µî ÅëÁ¦µÈ ÀÓ»ó ȯ°æ¿¡¼­ »ç¿ëÇϵµ·Ï °í¾ÈµÇ¾ú½À´Ï´Ù. ÀÌ Á¶Á¤ °¡´ÉÇÑ Ä§´ë¿¡´Â ÆÐµå, º£°³, ¿þÁö ¹× ±âŸ Æ÷Áö¼Å´× º¸Á¶ ÀåÄ¡µµ ÇÔ²² Á¦°øµË´Ï´Ù. ÀÏ¹Ý Ä§´ë¿Í ºñ±³ÇÏ¿©ÀÌ Ä§´ë¿Í ¸ÅÆ®¸®½º´Â °æÇ÷À» ³·Ãß°í, ü¿ÂÀ» Á¶ÀýÇϰí, ¿åâÀ» ¿¹¹æÇϰí, Ç÷·ù¸¦ °³¼±Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ÀüÀÚ½Ä ½Â°­ ÀåÄ¡, »çÀÌµå ·¹ÀÏ, ij½ºÅÍ¿Í °°Àº °í±Þ ±â´ÉÀ» °®Ãß°í ÀÖ¾î ȯÀÚ¿¡°Ô È޴뼺°ú ¾ÈÀü¼ºÀ» Á¦°øÇÕ´Ï´Ù. ¼ö¼ú, ºÎ»ó, ÅðÇ༺ ÁúȯÀÇ °æ¿ì, Ä¡·á¿ë ħ´ë´Â º´ »óÅ¿¡ µû¸¥ Æí¾ÈÇÔ°ú Æ÷Áö¼Å´×ÀÇ ¿ä±¸¸¦ ÃæÁ·½Ãŵ´Ï´Ù.

Ä¡·á¿ë ħ´ë ½ÃÀå µ¿Çâ:

¼¼°è ½ÃÀåÀº ÀÇ·á ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀÌ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â Çõ½ÅÀûÀÎ Á¦Ç° º¯ÇüÀÇ µµÀÔ¿¡ ÃÊÁ¡À» ¸ÂÃá ÁÖ¿ä ¾÷üµéÀÇ ±¤¹üÀ§ÇÑ ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, °Ç°­°ú À£ºù¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ »ó´çÈ÷ ³ô¾ÆÁø °Íµµ ½ÃÀåÀÇ Áß¿äÇÑ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿©·¯ ¸¸¼º Áúȯ¿¡ °É¸®±â ½±°í Àå±â ÀÔ¿øÀÌ ÇÊ¿äÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡°¡ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ÀÇ·áºñ ÁöÃâ È®´ë¿Í Àü¹ÝÀûÀÎ ÀÇ·á ÀÎÇÁ¶ó °³¼±À» À§ÇÑ °ø°ø ¹× ¹Î°£ ±â°üÀÇ ÀÚ±Ý Áö¿ø Áõ°¡´Â ¶Ç ´Ù¸¥ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±âŸ ½ÃÀå È®´ë ¿äÀÎÀ¸·Î´Â ¼ö¼ú Àü/ÈÄ ÁßȯÀÚ Ä¡·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, »ýȰ½À°üº´ À¯º´·ü Áõ°¡, ȯÀÚ Ä¡·á¿¡ ´ëÇÑ ÁöÃâ Áõ°¡, ȯÀÚ ¼ö ´ëºñ º´»ó ¼ö ºñÀ²À» °³¼±Çϱâ À§ÇÑ ÅõÀÚ Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé

  • 2023³â Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå ¼ºÀå·ü Àü¸ÁÀº?
  • Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • COVID-19°¡ ¼¼°è Ä¡·á¿ë ħ´ë ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå Á¦Ç°º° ºÐ·ù´Â?
  • Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå ¿ëµµº° ºÐ·ù´Â?
  • Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå ÃÖÁ¾»ç¿ëÀÚº° ºÐ·ù´Â?
  • Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå¿¡¼­ ÁÖ¿ä Áö¿ªÀº?
  • Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå ÁÖ¿ä ÁøÃâ ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå Ä¡·á¿ë ħ´ë ¼¼°è ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

  • ÀÓ»ó º£µå
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • ÀÏ¹Ý º´»ó
      • ICU º£µå
      • ¼Ò¾Æ¿ë º£µå
      • ºÐ¸¸¿ë º£µå
      • ºñ¸¸¿ë º£µå
      • Àú°ø±âºÐ ¼Õ½Ç º£µå
      • ±âŸ
    • ½ÃÀå ¿¹Ãø
  • °¡Á¤¿ë º£µå
  • ºÎ¼Óǰ

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ±Þ¼º±â ÀÇ·á¿ë º£µå
  • ÁßÁõ ȯÀÚ¿ë º£µå
  • Àå±â¿ë º£µå

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø¡¤Å¬¸®´Ð
  • »ý½Ä ÀÇ·á ¼¾ÅÍ
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï »óȲ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Amico Group of Companies
    • Arjo AB
    • Centrobed Ltd.
    • GF Health Products Inc.
    • HARD Manufacturing Company Inc.
    • Hill-Rom Holdings Inc.(Baxter International Inc.)
    • Invacare Corporation
    • Medical Depot Inc.(DBA Drive DeVilbiss Healthcare)
    • Medline Industries LP
    • Stryker Corporation
ksm 24.05.10

The global therapeutic beds market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.23% during 2024-2032.

Clinical therapeutic beds are specially designed beds that provide maximum patient comfort and improve healthcare delivery. These beds are intended to be used in controlled clinical environments, such as nursing homes, diagnostic laboratories, and outpatient clinics. Additional positioning aids, such as pads, pillows, and wedges, are also included with these adjustable beds. When compared to regular beds, these beds and mattresses are designed to lower acupoints, regulate body temperature, prevent bedsores, and improve blood flow. In addition to this, they are equipped with advanced features, such as electronic elevation, side rails, and wheels, thereby providing portability and safety for patients. In the event of surgery, injury, or degenerative disease, therapy beds fulfill the comfort and positioning needs associated with the medical condition.

Therapeutic Beds Market Trends:

The global market is majorly driven by continual technological advancements in the healthcare sector. This can be attributed to the extensive research and development (R&D) activities conducted by the key players focusing on introducing innovative product variants. In addition to this, a considerable rise in consumer awareness regarding health and wellness is acting as a significant growth-inducing factor for the market. The market is further propelled by the rising geriatric population susceptible to developing several chronic illnesses and requiring longer hospital stays. In line with this, the expanding medical expenditure and growing funding by public and private agencies to improve the overall healthcare infrastructure are acting as other major growth-inducing factors. Some of the other factors contributing to the market include the escalating demand for preoperative and postoperative critical care services, the rising prevalence of lifestyle-related diseases, growing expenditure on patient care, and increasing investments for improving the number of beds to patient ratio.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global therapeutic beds market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Clinical Beds

Regular Beds

ICU Beds

Pediatric Beds

Birthing Beds

Bariatric Beds

Low Air Loss Beds

Others

Household Beds

Accessories

Breakup by Application:

Acute Care Beds

Critical Care Beds

Long-term Beds

Breakup by End User:

Hospital and Clinics

Reproductive Care Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global therapeutic beds market in 2023?
  • 2. What is the expected growth rate of the global therapeutic beds market during 2024-2032?
  • 3. What are the key factors driving the global therapeutic beds market?
  • 4. What has been the impact of COVID-19 on the global therapeutic beds market?
  • 5. What is the breakup of the global therapeutic beds market based on the product?
  • 6. What is the breakup of the global therapeutic beds market based on the application?
  • 7. What is the breakup of the global therapeutic beds market based on end user?
  • 8. What are the key regions in the global therapeutic beds market?
  • 9. Who are the key players/companies in the global therapeutic beds market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Therapeutic Beds Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Clinical Beds
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Regular Beds
      • 6.1.2.2 ICU Beds
      • 6.1.2.3 Pediatric Beds
      • 6.1.2.4 Birthing Beds
      • 6.1.2.5 Bariatric Beds
      • 6.1.2.6 Low Air Loss Beds
      • 6.1.2.7 Others
    • 6.1.3 Market Forecast
  • 6.2 Household Beds
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Accessories
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Acute Care Beds
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Critical Care Beds
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Long-term Beds
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Reproductive Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amico Group of Companies
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Arjo AB
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Centrobed Ltd.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 GF Health Products Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 HARD Manufacturing Company Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Hill-Rom Holdings Inc. (Baxter International Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Invacare Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medical Depot Inc. (DBA Drive DeVilbiss Healthcare)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Medline Industries LP
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Stryker Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦